Observational studyJournal of cardiothoracic surgery2019

A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.

Etem Caliskan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.